Durvalumab compared to maintenance chemotherapy in patients with metastatic breast cancer: Results from phase II randomized trial SAFIR02-IMMUNO

被引：8

作者：

Dalenc, Florence ^{[1
]}

Garberis, Ingrid ^{[2
]}

Filleron, Thomas ^{[1
]}

Lusque, Amelie ^{[1
]}

Bachelot, Thomas ^{[3
]}

Arnedos, Monica ^{[2
]}

Campone, Mario ^{[4
]}

Sablin, Marie-Paule ^{[5
]}

Bonnefoi, Herve ^{[6
]}

Jimenez, Marta ^{[7
]}

Alexandra, Jacquet ^{[7
]}

Andre, Fabrice ^{[2
]}

机构：

[1] Inst Claudius Regaud, Toulouse, France

[2] Gustave Roussy, Villejuif, France

[3] Ctr Leon Berard, Lyon, France

[4] Inst Cancerol Ouest, St Herblain Angers, France

[5] Inst Curie, Paris, France

[6] Inst Bergonie, Bordeaux, France

[7] Unicancer, Le Kremlin Bicetre, France

来源：

关键词：

D O I：

10.1158/1538-7445.SABCS19-GS3-02

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

GS3-02

引用

页数：2